Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2022 | Alto Neuroscience | $35.0M Series B | Jeff Chen, Ph.D., Christopher Cox | 7BC Venture Capital, Champion Hill Labs, Crosscut Ventures, Scott Hartley, Future Africa, LombardStreet Ventures, Presight Capital, What If Ventures, Charles Delingpole, Christian Faes, Apeiron Investment Group, Gaingels, Korify Capital, Robert Baloh, Valor Equity Partners, Vine Ventures, Windham Venture Partners |
| Nov 1, 2020 | Decibel Therapeutics | $82.0M Series D | Peter Thompson | GV, The Column Group, Versant Ventures, BlackRock, Casdin Capital, Foresite Capital, Janus Henderson Investors, Samsara BioCapital, S-Cubed Capital, SR One, Surveyor Capital, Third Rock Ventures |